49 filings
Page 2 of 3
8-K
7b3g9pdq3q5
12 Dec 22
Other Events
5:36pm
8-K
whk4fmbz8awh319hq
26 Oct 22
Other Events
7:06am
8-K
4k4fg7pslsbivgo pu
6 Oct 22
Nurix Therapeutics Reports Third Quarter Fiscal 2022 Financial Results and Provides a Corporate Update
4:10pm
8-K
n9vkg9l
14 Sep 22
Nurix Therapeutics Appoints Leading Industry Strategist Edward C. Saltzman to its Board of Directors
4:01pm
8-K
j40tz
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
8-K
fcq9uev01 36zwh44mr
7 Jul 22
Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update
4:09pm
8-K
w28c6 m7yc8a
26 May 22
Other Events
7:02am
8-K
rbp91ywjlh5sadmpy
16 May 22
Departure of Directors or Certain Officers
6:08am
8-K
su833pa
6 May 22
Submission of Matters to a Vote of Security Holders
7:00am
8-K
1qjz g5h1hava
7 Apr 22
Nurix Therapeutics Reports Fiscal First Quarter 2022 Financial Results and Provides a Corporate Update
4:08pm
8-K
qp7r2zxfef0u
7 Mar 22
Departure of Directors or Certain Officers
4:05pm
8-K
aj0 zcps9os
2 Mar 22
Entry into a Material Definitive Agreement
4:07pm
8-K
0rvn5lkippoi
27 Jan 22
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides a Corporate Update
4:07pm
8-K
1l9wrrtbj4g
10 Jan 22
Other Events
7:11am
8-K
hrd3g4orufm95k7p04e6
27 Oct 21
Other Events
7:01am
8-K
sqi82oj0fzez 9h
14 Oct 21
Nurix Therapeutics Reports Third Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
5:10pm
8-K
zua7hw mg01sff
30 Sep 21
Nurix Therapeutics Expands its Board of Directors with the Addition of Two Industry Leaders
7:08am
8-K
872gz
13 Jul 21
Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
4:12pm
8-K
r3sdcvj2kys5o vq0z
9 Jul 21
Entry into a Material Definitive Agreement
4:27pm
8-K
bcrhxm3tz47zt b474l
21 Jun 21
Departure of Directors or Certain Officers
4:17pm